Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aerie Pharmaceuticals Inc (AERI)  
$15.25 0.00 (0.00%) as of 4:30 Fri 11/18


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 47,361,000
Market Cap: 722.26(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $15.25 - $15.25
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Aerie Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of ophthalmic therapies for the treatment of patients with eye diseases and conditions including open-angle glaucoma, dry eye, and diabetic macular edema. Rhopressa® is a once-daily eye drop designed to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Rocklatan® is a once-daily fixed-dose combination of Rhopressa® and latanoprost, a prescribed drug for the treatment of patients with open-angle glaucoma or ocular hypertension. Co. is developing AR-15512, an ophthalmic solution for the treatment of patients with dry eye disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 333
  Page 10 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Anido Vicente Jr Chief Executive Officer   •       •      –    2018-04-12 4 D $53.40 $168,157 D/D (3,149) 130,777     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2018-04-12 4 A $0.00 $0 D/D 21,448 133,926     -
   Mitro Thomas A President and COO   •       –      –    2018-02-25 4 D $53.85 $55,304 D/D (1,027) 51,479     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-02-25 4 D $53.85 $29,025 D/D (539) 191,517     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2018-02-25 4 D $53.85 $72,751 D/D (1,351) 126,320     -
   Rubino Richard J Chief Financial Officer   •       –      –    2018-02-25 4 D $53.85 $41,788 D/D (776) 418,250     -
   Mitro Thomas A President and COO   •       –      –    2018-02-24 4 D $53.85 $55,304 D/D (1,027) 52,506     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-02-24 4 D $53.85 $36,295 D/D (674) 192,056     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2018-02-24 4 D $53.85 $110,608 D/D (2,054) 127,671     -
   Rubino Richard J Chief Financial Officer   •       –      –    2018-02-24 4 D $53.85 $46,149 D/D (857) 419,026     -
   Mitro Thomas A President and COO   •       –      –    2018-02-23 4 D $53.85 $41,088 D/D (763) 53,533     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-02-23 4 D $53.85 $17,824 D/D (331) 192,730     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2018-02-23 4 D $53.85 $56,650 D/D (1,052) 129,725     -
   Rubino Richard J Chief Financial Officer   •       –      –    2018-02-23 4 D $53.85 $22,079 D/D (410) 419,883     -
   Larocca John General Counsel   •       –      –    2018-02-19 4 A $0.00 $0 D/D 18,000 18,000     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-02-09 4 D $52.55 $1,314 D/D (25) 139,743     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-02-09 4 OE $0.40 $1,284 D/D 3,251 139,768     -
   Rubino Richard J Chief Financial Officer   •       –      –    2018-02-08 4 A $0.00 $0 D/D 10,667 412,802     -
   Mitro Thomas A President and COO   •       –      –    2018-02-08 4 A $0.00 $0 D/D 12,778 46,820     -
   Kopczynski Casey C. Chief Scientific Officer   •       –      –    2018-02-08 4 A $0.00 $0 D/D 8,000 193,061     -
   Anido Vicente Jr Chief Executive Officer   •       •      –    2018-02-08 4 A $0.00 $0 D/D 25,413 112,478     -
   Croarkin Richard Director   –       •      –    2017-06-08 4 A $0.00 $0 D/D 1,150 2,850     -
   Mcgraw Benjamin F III Director   –       •      –    2017-06-08 4 A $0.00 $0 D/D 1,150 4,550     -
   Mchugh Julie Director   –       •      –    2017-06-08 4 A $0.00 $0 D/D 1,150 2,850     -
   Cagle Gerald D. Director   –       •      –    2017-06-08 4 A $0.00 $0 D/D 1,150 14,050     -
  333 Records found
  Previous  10  11  12  13  14   
  Page 10 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us